BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30917957)

  • 1. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
    Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
    Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
    Newman PM; Chong BH
    Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
    Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
    Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia.
    Gerotziafas GT; Elalamy I; Lecrubier C; Lebrazi J; Mirshahi M; Potevin F; Lecompte T; Samama MM
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):511-20. PubMed ID: 11685038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
    Pouplard C; Rollin J; Vayne C; Charuel N; Ahmadi Z; Alberio L; Azjenberg N; Althaus K; Bakchoul T; Chong B; Curtis BR; Faille D; Gomez FJ; Gresele P; Morel-Kopp MC; Mullier F; Nazy I; Smith JW; Greinacher A; Gruel Y
    J Thromb Haemost; 2022 Jan; 20(1):252-259. PubMed ID: 34657390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
    Greinacher A; Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
    Rollin J; Pouplard C; Sung HC; Leroux D; Saada A; Gouilleux-Gruart V; Thibault G; Gruel Y
    Blood; 2015 Apr; 125(15):2397-404. PubMed ID: 25680756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
    Horne MK; Hutchison KJ
    Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies.
    Wolff M; Handtke S; Palankar R; Wesche J; Kohler TP; Kohler C; Gruel Y; Hammerschmidt S; Greinacher A
    J Thromb Haemost; 2020 Jun; 18(6):1459-1468. PubMed ID: 32237268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
    Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
    J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia.
    Hayes V; Johnston I; Arepally GM; McKenzie SE; Cines DB; Rauova L; Poncz M
    J Clin Invest; 2017 Mar; 127(3):1090-1098. PubMed ID: 28218620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
    Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcRn augments induction of tissue factor activity by IgG-containing immune complexes.
    Cines DB; Zaitsev S; Rauova L; Rux AH; Stepanova V; Krishnaswamy S; Sarkar A; Kowalska MA; Zhao G; Mast AE; Blumberg LJ; McCrae KR; Poncz M; Hubbard JJ; Pyzik M; Blumberg RS
    Blood; 2020 Jun; 135(23):2085-2093. PubMed ID: 32187355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
    Sarkar A; Khandelwal S; Koma GT; Kim H; Gruel Y; Rollin J; Passam F; Wool GD; Arepally GM; Cines DB; Rauova L; Poncz M
    Blood Adv; 2023 Aug; 7(15):4112-4123. PubMed ID: 37196641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.
    Rollin J; Pouplard C; Gratacap MP; Leroux D; May MA; Aupart M; Gouilleux-Gruart V; Payrastre B; Gruel Y
    Blood; 2012 Aug; 120(6):1309-16. PubMed ID: 22677127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.
    Krauel K; Pötschke C; Weber C; Kessler W; Fürll B; Ittermann T; Maier S; Hammerschmidt S; Bröker BM; Greinacher A
    Blood; 2011 Jan; 117(4):1370-8. PubMed ID: 20959601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.